What is the market doing?
What the tape says about ABCL
AbCellera Biologics Inc. is +145% over the past year while the S&P 500 is +20%: 125 points ahead of the market.
+145%
1-year return · S&P 500 +20%
- vs 200-day average
- +130%
vs 200-day average · a clear uptrend
- RSI (14)
- 52
RSI (14) · neutral
- Below its 52-week high
- 8.5%
Below its 52-week high
Details›
- Last close2026-09-08
- $11.44
- 1 monthS&P 500 −0.30%
- +75%
- 1 yearS&P 500 +20%
- +145%
- 5 yearsS&P 500 +85%
- −25%
- vs 50-day average$8.02
- +43%
- 52-week high
- $12.50
- 52-week low
- $2.78
- Annualised volatility
- 78%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- $952K
| Year | Return |
|---|---|
| 2026 (year to date) | +235% |
| 2025 | +17% |
| 2024 | −49% |
| 2023 | −44% |
| 2022 | −29% |
| 2021 | −64% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 6 | 4 of 6 | +0.27% |
| Feb | 6 | 0 of 6 | −12% |
| Mar | 6 | 1 of 6 | −5.9% |
| Apr | 6 | 2 of 6 | −5.6% |
| May | 6 | 4 of 6 | +5.4% |
| Jun | 6 | 3 of 6 | +11% |
| Jul | 6 | 3 of 6 | +0.46% |
| Aug | 6 | 3 of 6 | +13% |
| Sep | 6 | 3 of 6 | +3.0% |
| Oct | 5 | 3 of 5 | +0.54% |
| Nov | 5 | 3 of 5 | −0.78% |
| Dec | 5 | 1 of 5 | −3.1% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.